Portfolio Category: Current






Ventyx Biosciences
Developing selective inhibitors of TYK2 for autoimmune diseases.
Read More

DUST Identity
Utilizes diamond crystals to enable secure identification of physical objects.
Read More


NorthSea Therapeutics
Focused on the development of first-in-class therapeutics for NASH and other metabolic, inflammatory and fibrotic diseases.
Read More